The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler approved by the FDA for the relief of asthma ...

Primatene Mist inhalers (epinephrine inhalation aerosol) provide temporary relief from mild, intermittent asthma symptoms. The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler ...

Amphastar's Q2 2024 revenue grew 25% year-over-year to $182.4 million, primarily driven by BAQSIMI and Primatene MIST sales. Primatene MIST faces future challenges as its key patent expires in ...

A key highlight for the quarter was Primatene MIST which achieved its highest quarterly sales since the launch reaching $26 million in sales. This performance is a significant step toward our goal ...

After hours: November 13 at 4:27 PM EST Loading Chart for AMPH ...

Our strategic initiatives regarding our regulatory filings and commercial portfolio execution remain on track and we are well positioned to continue the growth of our key revenue drivers with BAQSIMI, ...

Headaches, including migraines, are common. It is estimated that one out of every six Americans experiences migraines or severe headaches. Over-the-counter (OTC) medications for migraines are ...

It was only two years ago that hearing aids became available over the counter in the US, but the positive impact of these devices is long-standing. And they've proven themselves as great tools for ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...